This site complies with the HONcode standard for trustworthy health information:
verify here.

Rewarding for
you and us
Defeat Diabetes Foundation

Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300
Madeira Beach, FL 33708

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase. The latest article will appear first.

Plavix-Aspirin Combo No Better than Aspirin Alone for CVD Event Reduction

Posted: Friday, March 24, 2006

The CHARISMA trial of aspirin alone vs. aspirin plus Plavix (clopidogrel) showed no benefit over aspirin alone at preventing major cardiovascular events or death.

In addition to finding no significant benefit for the combination in a randomized trial in more than 15,000 patients, Plavix plus aspirin for patients with multiple risk factors was associated with increased risk for moderate and serious bleeding

U.S. Diabetes Population Grows 86 Percent Over Last Decade

Posted: Thursday, March 16, 2006

Research reveals diabetes complications are widespread and growing, and patients desire to gain better control.

Adding a 2nd Glucose Lowering Drug is More Effective than Maximizing a Single Drug

Posted: Monday, March 13, 2006

Major type 2 diabetes study shows significant improvement in blood sugar control and patients demonstrate high adherence and achieve aggressive treatment targets.

Statin Therapy for Type 2’s Regardless of LDL Levels and CVD

Posted: Monday, March 13, 2006

The incidence of type 2 diabetes mellitus is expected to increase dramatically over the next decade. Patients with type 2 diabetes are at a much greater risk for cardiovascular disease (CVD) than are nondiabetic individuals. Consequently, the treatment of CVD risk factors is a healthcare priority in this patient population.

Merck Announces FDA Acceptance Of New Drug Application For JANUVIA™

Posted: Thursday, March 09, 2006

JANUVIA is an investigational once-daily medicine with a novel mechanism of action for the treatment of type 2 diabetes.
If approved, JANUVIA would potentially be the first in a new class of oral medications (DPP-4 inhibitors) that enhances the body's own ability to lower blood sugar (glucose) when it is elevated

When Viagra Doesn't Work, Lipitor May Assist

Posted: Thursday, March 09, 2006

Eight men with erectile dysfunction who didn't respond to Viagra initially reported that the drug worked better after six weeks of taking Lipitor daily, Results of the study, suggested that erectile dysfunction may be one sign of a generalized vascular disorder characterized by endothelial dysfunction

High Drop Out Rate for Rimonabant Diet

Posted: Tuesday, March 07, 2006

The investigational diet drug Acomplia (rimonabant) has staying power for weight loss and slimmer waists, and can improve lipids, but half of the participants dropped out of the study before the 2-year study was completed.

So Acomplia, which has been widely touted a revolutionary diet drug, seems stymied by the same problem faced by all diet medications-that patients are unwilling to stick with the drug for the long haul

Rimonabant Lowers Weight, Helps Correct Metabolic Syndrome

Posted: Tuesday, March 07, 2006

Results from new 2-year study shows the agent also improved cardiometabolic risk factors even more than the amount of weight loss would have predicted

Statins Cut the Risk of Serious Infection

Posted: Thursday, February 16, 2006

According to scientists: Cholesterol-lowering drugs, known as statins, can reduce the risk of severe infection in patients suffering from heart disease or stroke.

Rise in Aspirin Use Seen Among US Adults

Posted: Thursday, February 09, 2006

Aspirin use among US adults rose about 20% from 1999 to 2003, and the Healthy People 2010 objective of having at least 30% of diabetics use this drug on a regular basis has been met.